Compare $NRXS vs $OM | Chartloom

Compare

$NRXS vs $OM

Neuraxis Inc · Outset Medical Inc

NRXS

Neuraxis Inc

Outset Medical Inc

Compare $NRXS vs $OM

Comparing Neuraxis Inc and Outset Medical Inc

NRXSNeuraxis Inc

OMOutset Medical Inc

NRXSNeuraxis Inc

Market cap

$86M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

6.62x

Rev growth (TTM)

65.2%

YTD performance

55.4%

52W performance

121.4%

FCF yield

-6.7%

OMOutset Medical Inc

Market cap

$75M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

0.56x

Rev growth (TTM)

-1.3%

YTD performance

9.5%

52W performance

-74.4%

FCF yield

-51.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

NRXS

Detailed metrics comparison

NRXS

Neuraxis Inc

Outset Medical Inc

Market Cap

NRXS$86M

OM$75M

Enterprise Value

NRXS$78M

OM$138M

Price

NRXS$6.93

OM$4.05

P/E Ratio

NRXSN/A

OMN/A

P/S Ratio

NRXS16.14x

OM0.64x

EV/Sales

NRXS14.58x

OM1.17x

EV/EBITDA

NRXS0.00x

OM0.00x

P/B Ratio

NRXS13.26x

OM0.77x

P/FCF Ratio

NRXSN/A

OMN/A

EV/FCF

NRXS-13.52x

OM-3.56x

PEG Ratio

NRXSN/A

OMN/A

Forward P/E (NTM)

NRXSN/A

OMN/A

Forward P/S (NTM)

NRXS6.62x

OM0.56x

Revenue (TTM)

NRXS$5M

OM$118M

Revenue Growth (YoY)

NRXS65.2%

OM-1.3%

Forward Rev Growth

NRXS124.9%

OM10.5%

Gross Margin (TTM)

NRXS85.6%

OM41.8%

Operating Margin (TTM)

NRXS0.0%

OM0.0%

EBITDA Margin (TTM)

NRXS-143.1%

OM-53.2%

Net Margin (TTM)

NRXS-159.0%

OM-63.1%

FCF Margin (TTM)

NRXS-107.8%

OM-33.0%

Net Income (TTM)

NRXS$-8M

OM$-74M

FCF (TTM)

NRXS$-6M

OM$-39M

EPS (TTM)

NRXS-$0.70

OM-$3.99

ROE (TTM)

NRXS-16907.0%

OM-6225.0%

ROA (TTM)

NRXS-9933.0%

OM-2875.0%

ROIC (TTM)

NRXS-16465.0%

OM-3438.0%

Cash

NRXS$8M

OM$35M

Debt

NRXS$43K

OM$98M

Net Cash/Debt

NRXS$8M

OM$-63M

Current Ratio (TTM)

NRXS3.04x

OM5.19x

Quick Ratio (TTM)

NRXS2.83x

OM4.02x

Debt/Equity (TTM)

NRXS0.01x

OM1.02x

Debt/Assets (TTM)

NRXS0.0%

OM0.0%

Interest Coverage (TTM)

NRXSN/A

OMN/A

Net Debt/EBITDA (TTM)

NRXS0.00x

OM0.00x

Beta

NRXS1.40

OM2.01

52W Performance

NRXS121.4%

OM-74.4%

YTD Performance

NRXS55.4%

OM9.5%

% from 52W High

NRXS-25.7%

OM-74.9%

% from 52W Low

NRXS213.6%

OM42.6%

Asset Turnover (TTM)

NRXS0.69x

OM0.46x

FCF Yield (TTM)

NRXS-6.7%

OM-51.8%

Earnings Yield (TTM)

NRXS-9.9%

OM-98.9%

Dividend Yield (TTM)

NRXSN/A

OMN/A

Rule of 40

NRXS-42.6

OM-34.3

EV/GP/RG

NRXS0.12

OM0.04

Ticker research

View NRXS research View OM research

Metric	NRXS Neuraxis Inc	OM Outset Medical Inc
Market & Valuation
Market Cap	$86M	$75M
Enterprise Value	$78M	$138M
Price	$6.93	$4.05
P/E Ratio	N/A	N/A
P/S Ratio	16.14x	0.64x
EV/Sales	14.58x	1.17x
EV/EBITDA	0.00x	0.00x
P/B Ratio	13.26x	0.77x
P/FCF Ratio	N/A	N/A
EV/FCF	-13.52x	-3.56x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	6.62x	0.56x
Revenue & Growth
Revenue (TTM)	$5M	$118M
Revenue Growth (YoY)	65.2%	-1.3%
Forward Rev Growth	124.9%	10.5%
Profitability
Gross Margin (TTM)	85.6%	41.8%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-143.1%	-53.2%
Net Margin (TTM)	-159.0%	-63.1%
FCF Margin (TTM)	-107.8%	-33.0%
Net Income (TTM)	$-8M	$-74M
FCF (TTM)	$-6M	$-39M
EPS (TTM)	-$0.70	-$3.99
ROE (TTM)	-16907.0%	-6225.0%
ROA (TTM)	-9933.0%	-2875.0%
ROIC (TTM)	-16465.0%	-3438.0%
Financial Health
Cash	$8M	$35M
Debt	$43K	$98M
Net Cash/Debt	$8M	$-63M
Current Ratio (TTM)	3.04x	5.19x
Quick Ratio (TTM)	2.83x	4.02x
Debt/Equity (TTM)	0.01x	1.02x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.40	2.01
52W Performance	121.4%	-74.4%
YTD Performance	55.4%	9.5%
% from 52W High	-25.7%	-74.9%
% from 52W Low	213.6%	42.6%
Efficiency & Yields
Asset Turnover (TTM)	0.69x	0.46x
FCF Yield (TTM)	-6.7%	-51.8%
Earnings Yield (TTM)	-9.9%	-98.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-42.6	-34.3
EV/GP/RG	0.12	0.04
Ticker research	View NRXS research	View OM research

Valuation

P/S Ratio

0.64x

NRXS

16.14x

EV/FCF

NRXS

-13.52x

-3.56x

Growth & revenue

Revenue Growth TTM

NRXS

65.2%

-1.3%

Forward Revenue Growth

NRXS

124.9%

10.5%

Profitability & performance

Gross Margin

NRXS

85.6%

41.8%

ROE

-6225.0%

NRXS

-16907.0%

FCF Yield %

NRXS

-6.7%

-51.8%

52-Week Performance

NRXS

121.4%

-74.4%

Detailed metrics comparison

NRXS

Neuraxis Inc

Outset Medical Inc

Market Cap

NRXS$86M

OM$75M

Enterprise Value

NRXS$78M

OM$138M

Price

NRXS$6.93

OM$4.05

P/E Ratio

NRXSN/A

OMN/A

P/S Ratio

NRXS16.14x

OM0.64x

EV/Sales

NRXS14.58x

OM1.17x

EV/EBITDA

NRXS0.00x

OM0.00x

P/B Ratio

NRXS13.26x

OM0.77x

P/FCF Ratio

NRXSN/A

OMN/A

EV/FCF

NRXS-13.52x

OM-3.56x

PEG Ratio

NRXSN/A

OMN/A

Forward P/E (NTM)

NRXSN/A

OMN/A

Forward P/S (NTM)

NRXS6.62x

OM0.56x

Revenue (TTM)

NRXS$5M

OM$118M

Revenue Growth (YoY)

NRXS65.2%

OM-1.3%

Forward Rev Growth

NRXS124.9%

OM10.5%

Gross Margin (TTM)

NRXS85.6%

OM41.8%

Operating Margin (TTM)

NRXS0.0%

OM0.0%

EBITDA Margin (TTM)

NRXS-143.1%

OM-53.2%

Net Margin (TTM)

NRXS-159.0%

OM-63.1%

FCF Margin (TTM)

NRXS-107.8%

OM-33.0%

Net Income (TTM)

NRXS$-8M

OM$-74M

FCF (TTM)

NRXS$-6M

OM$-39M

EPS (TTM)

NRXS-$0.70

OM-$3.99

ROE (TTM)

NRXS-16907.0%

OM-6225.0%

ROA (TTM)

NRXS-9933.0%

OM-2875.0%

ROIC (TTM)

NRXS-16465.0%

OM-3438.0%

Cash

NRXS$8M

OM$35M

Debt

NRXS$43K

OM$98M

Net Cash/Debt

NRXS$8M

OM$-63M

Current Ratio (TTM)

NRXS3.04x

OM5.19x

Quick Ratio (TTM)

NRXS2.83x

OM4.02x

Debt/Equity (TTM)

NRXS0.01x

OM1.02x

Debt/Assets (TTM)

NRXS0.0%

OM0.0%

Interest Coverage (TTM)

NRXSN/A

OMN/A

Net Debt/EBITDA (TTM)

NRXS0.00x

OM0.00x

Beta

NRXS1.40

OM2.01

52W Performance

NRXS121.4%

OM-74.4%

YTD Performance

NRXS55.4%

OM9.5%

% from 52W High

NRXS-25.7%

OM-74.9%

% from 52W Low

NRXS213.6%

OM42.6%

Asset Turnover (TTM)

NRXS0.69x

OM0.46x

FCF Yield (TTM)

NRXS-6.7%

OM-51.8%

Earnings Yield (TTM)

NRXS-9.9%

OM-98.9%

Dividend Yield (TTM)

NRXSN/A

OMN/A

Rule of 40

NRXS-42.6

OM-34.3

EV/GP/RG

NRXS0.12

OM0.04

Ticker research

View NRXS research View OM research

Metric	NRXS Neuraxis Inc	OM Outset Medical Inc
Market & Valuation
Market Cap	$86M	$75M
Enterprise Value	$78M	$138M
Price	$6.93	$4.05
P/E Ratio	N/A	N/A
P/S Ratio	16.14x	0.64x
EV/Sales	14.58x	1.17x
EV/EBITDA	0.00x	0.00x
P/B Ratio	13.26x	0.77x
P/FCF Ratio	N/A	N/A
EV/FCF	-13.52x	-3.56x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	6.62x	0.56x
Revenue & Growth
Revenue (TTM)	$5M	$118M
Revenue Growth (YoY)	65.2%	-1.3%
Forward Rev Growth	124.9%	10.5%
Profitability
Gross Margin (TTM)	85.6%	41.8%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-143.1%	-53.2%
Net Margin (TTM)	-159.0%	-63.1%
FCF Margin (TTM)	-107.8%	-33.0%
Net Income (TTM)	$-8M	$-74M
FCF (TTM)	$-6M	$-39M
EPS (TTM)	-$0.70	-$3.99
ROE (TTM)	-16907.0%	-6225.0%
ROA (TTM)	-9933.0%	-2875.0%
ROIC (TTM)	-16465.0%	-3438.0%
Financial Health
Cash	$8M	$35M
Debt	$43K	$98M
Net Cash/Debt	$8M	$-63M
Current Ratio (TTM)	3.04x	5.19x
Quick Ratio (TTM)	2.83x	4.02x
Debt/Equity (TTM)	0.01x	1.02x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.40	2.01
52W Performance	121.4%	-74.4%
YTD Performance	55.4%	9.5%
% from 52W High	-25.7%	-74.9%
% from 52W Low	213.6%	42.6%
Efficiency & Yields
Asset Turnover (TTM)	0.69x	0.46x
FCF Yield (TTM)	-6.7%	-51.8%
Earnings Yield (TTM)	-9.9%	-98.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-42.6	-34.3
EV/GP/RG	0.12	0.04
Ticker research	View NRXS research	View OM research